Clene (CLNN) Short Interest Ratio & Short Volume → Time is Running Out - June 25th Deadline Approaching! (From Paradigm Press) (Ad) Free CLNN Stock Alerts $0.37 +0.02 (+5.69%) (As of 06/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Clene Short Interest DataCurrent Short Interest209,000 sharesPrevious Short Interest674,500 sharesChange Vs. Previous Month-69.01%Dollar Volume Sold Short$79,963.40Short Interest Ratio0.2 Days to CoverLast Record DateMay 15, 2024Outstanding Shares128,430,000 sharesPercentage of Shares Shorted0.16%Today's Trading Volume1,378,488 sharesAverage Trading Volume867,781 sharesToday's Volume Vs. Average159% Short Selling Clene ? Sign up to receive the latest short interest report for Clene and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCLNN Short Interest Over TimeCLNN Days to Cover Over TimeCLNN Percentage of Float Shorted Over Time Ad Porter & CompanySecret energy grid to power millions of homesThis high-security, secret U.S. facility has 2,100 engineers, machinists, and technicians building a new type of energy system the world has never seen before.Click here to get all the details. Clene Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024209,000 shares $79,963.40 -69.0%N/A0.2 $0.38 4/30/2024674,500 shares $291,249.10 +354.2%N/A0.7 $0.43 4/15/2024148,500 shares $49,212.90 -8.8%N/A0.2 $0.33 3/31/2024162,900 shares $69,297.66 -37.9%N/A0.2 $0.43 3/15/2024262,500 shares $105,000.00 -38.5%N/A0.2 $0.40 2/29/2024427,100 shares $171,865.04 +86.8%N/A0.4 $0.40 Get the Latest News and Ratings for CLNN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Clene and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024228,700 shares $105,224.87 +2.9%N/A0.2 $0.46 1/31/2024222,300 shares $109,816.20 -22.6%N/A0.2 $0.49 1/15/2024287,200 shares $137,798.56 -66.1%N/A0.3 $0.48 12/31/2023846,000 shares $250,923.60 +91.5%N/A1 $0.30 12/15/2023441,800 shares $185,644.36 -25.5%N/A0.7 $0.42 11/30/2023592,800 shares $259,646.40 +1.9%N/A1.4 $0.44 11/15/2023581,900 shares $256,617.90 -15.4%N/A1.4 $0.44 10/31/2023687,500 shares $268,125.00 -13.0%N/A1.7 $0.39 10/15/2023790,600 shares $402,415.40 -2.0%N/A1.9 $0.51 9/30/2023806,900 shares $400,141.71 +52.1%N/A1.8 $0.50 9/15/2023530,500 shares $286,470.00 +29.3%N/A1 $0.54 8/31/2023410,400 shares $295,488.00 -28.4%N/A0.7 $0.72 8/15/2023572,800 shares $426,736.00 -4.3%N/A1.1 $0.75 7/31/2023598,300 shares $464,280.80 -47.5%2.5%1.2 $0.78 7/15/20231,140,000 shares $912,114.00 -2.6%4.8%2.4 $0.80 6/30/20231,170,000 shares $1.03 million -28.7%4.8%2.7 $0.88 6/15/20231,640,000 shares $1.72 million -8.4%5.5%5.2 $1.05 5/31/20231,790,000 shares $1.74 million +1.1%5.8%7 $0.97 5/15/20231,770,000 shares $1.58 million -4.8%5.8%5.6 $0.90 4/30/20231,860,000 shares $1.77 million -1.1%6.2%1.8 $0.95 4/15/20231,880,000 shares $1.97 million +2.7%6.2%1.8 $1.05 3/31/20231,830,000 shares $2.07 million -16.4%6.5%1.8 $1.13 3/15/20232,190,000 shares $2.87 million +17.1%7.8%2.1 $1.31 2/28/20231,870,000 shares $2.36 million -37.9%6.7%2 $1.26 2/15/20233,010,000 shares $3.82 million +64.5%11.1%3.4 $1.27 1/31/20231,830,000 shares $2.80 million -19.0%6.8%9.7 $1.53 1/15/20232,260,000 shares $2.96 million -0.9%8.3%8.8 $1.31 12/30/20222,280,000 shares $2.28 million -5.4%8.7%9 $1.00 12/15/20222,410,000 shares $2.68 million -3.6%9.2%6.7 $1.11 11/30/20222,500,000 shares $2.65 million -8.4%13.5%7.2 $1.06 11/15/20222,730,000 shares $2.87 million -19.2%14.7%7.6 $1.05 10/31/20223,380,000 shares $3.35 million +13.0%18.0%8.8 $0.99 10/15/20222,990,000 shares $4.49 million -25.4%14.1%8.9 $1.50 9/30/20224,010,000 shares $11.23 million No Change18.9%3.3 $2.80No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (Ad)Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight!TRY "INVESTING IDEAS" TODAY 9/15/20224,010,000 shares $12.03 million +2.3%18.9%3.3 $3.00 8/31/20223,920,000 shares $11.60 million +25.6%15.3%3.2 $2.96 8/15/20223,120,000 shares $11.39 million +14.3%12.3%2.5 $3.65 7/31/20222,730,000 shares $9.15 million +11.4%10.7%2.3 $3.35 7/15/20222,450,000 shares $11.03 million -2.8%9.6%2.1 $4.50 6/30/20222,520,000 shares $6.35 million -21.5%9.9%9.8 $2.52 6/15/20223,210,000 shares $8.51 million -0.3%12.6%13.3 $2.65 5/31/20223,220,000 shares $7.02 million -4.2%12.5%25.1 $2.18 5/15/20223,360,000 shares $7.06 million +9.1%13.0%31.3 $2.10 4/30/20223,080,000 shares $7.98 million +5.5%11.9%31.5 $2.59 4/15/20222,920,000 shares $8.94 million -1.4%11.4%29 $3.06 3/31/20222,960,000 shares $11.66 million +9.2%11.7%25.3 $3.94 3/15/20222,710,000 shares $6.56 million +1.5%10.7%22.3 $2.42 2/28/20222,670,000 shares $8.25 million No Change10.7%16.8 $3.09 2/15/20222,670,000 shares $8.12 million +1.5%10.7%14.6 $3.04 1/31/20222,630,000 shares $7.39 million +9.1%12.2%13 $2.81 1/15/20222,410,000 shares $7.23 million +5.7%N/A10.2 $3.00 12/31/20212,280,000 shares $9.35 million -0.4%10.7%10.1 $4.10 12/15/20212,290,000 shares $12.18 million +9.6%10.8%9.8 $5.32 11/30/20212,090,000 shares $11.89 million -3.2%10.0%10.5 $5.69 11/15/20212,160,000 shares $13.02 million +15.5%10.3%12 $6.03 10/29/20211,870,000 shares $10.15 million +18.4%8.9%10.8 $5.43 10/15/20211,580,000 shares $9.75 million +6.8%4.6%10.4 $6.17 9/30/20211,480,000 shares $10.11 million -1.3%4.3%3.4 $6.83 9/15/20211,500,000 shares $11.15 million -1.3%4.4%3.2 $7.43 8/31/20211,520,000 shares $12.16 million +16.0%4.5%3.2 $8.00 8/13/20211,310,000 shares $11.19 million No Change3.8%2.7 $8.54 7/30/20211,310,000 shares $11.27 million -8.4%3.8%2.8 $8.60 7/15/20211,430,000 shares $14.19 million +26.6%4.2%3.1 $9.92 6/30/20211,130,000 shares $12.70 million +55.4%57.1%3.4 $11.24 6/15/2021727,200 shares $8.16 million +23.0%36.7%6.2 $11.22 5/28/2021591,400 shares $6.74 million +7.0%29.9%4.3 $11.40 5/14/2021552,600 shares $3.86 million +24.4%27.9%4.1 $6.98 4/30/2021444,300 shares $4.16 million +35.7%22.4%2.9 $9.36 4/15/2021327,400 shares $4.22 million -7.3%16.5%1.3 $12.89 3/31/2021353,000 shares $4.90 million +64.1%18.3%1.5 $13.89 3/15/2021215,100 shares $3.07 million +11.2%11.2%0.8 $14.25 2/26/2021193,500 shares $2.52 million +70.3%10.0%0.8 $13.03 2/12/2021113,600 shares $1.23 million +94.5%5.9%0.5 $10.79 1/29/202158,400 shares $379,016.00 +1,617.7%2.7%0.3 $6.49 1/15/20213,400 shares $23,562.00 No Change0.2%0.1 $6.93 CLNN Short Interest - Frequently Asked Questions What is Clene's current short interest? Short interest is the volume of Clene shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 209,000 shares of CLNN short. Learn More on Clene's current short interest. Which institutional investors are shorting Clene? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Clene: CVI Holdings LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Clene's short interest increasing or decreasing? Clene saw a decrease in short interest in May. As of May 15th, there was short interest totaling 209,000 shares, a decrease of 69.0% from the previous total of 674,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Clene's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Clene: Atossa Therapeutics, Inc. (9.13%), Sagimet Biosciences Inc. (10.29%), Rezolute, Inc. (0.77%), Alimera Sciences, Inc. (0.20%), ProQR Therapeutics (0.45%), Seres Therapeutics, Inc. (15.01%), Context Therapeutics Inc. (1.38%), Regulus Therapeutics Inc. (5.44%), Veru Inc. (8.65%), Repare Therapeutics Inc. (1.82%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Clene stock? Short selling CLNN is an investing strategy that aims to generate trading profit from Clene as its price is falling. CLNN shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Clene? A short squeeze for Clene occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLNN, which in turn drives the price of the stock up even further. How often is Clene's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLNN, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Atossa Therapeutics Short Interest Data Sagimet Biosciences Short Interest Data Rezolute Short Interest Data Alimera Sciences Short Interest Data ProQR Therapeutics Short Interest Data Seres Therapeutics Short Interest Data Context Therapeutics Short Interest Data Regulus Therapeutics Short Interest Data Veru Short Interest Data Repare Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLNN) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s...Weiss Ratings | SponsoredMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.